FERRING

In News

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire

PR Newswire - Sep 01, 2026

RedHill Biopharma Buys Global Rights to Two Established GI Drugs from Ferring - BioBuzz

BioBuzz - Sep 17, 2026

Microbiome Patent Litigation update: Ferring v. Finch decision made final but may now head to appeal - Nixon Peabody

Nixon Peabody - Jul 08, 2026

‘Portfolio assessment’ prompts Ferring to terminate 2 fertility trials - Fierce Biotech

Fierce Biotech - Apr 02, 2026

Microbiome Therapeutics Market Report 2026-2035 Featuring Profiles of Ferring Pharmaceuticals, Infant Bacterial Therapeutics, MaaT Pharma, Mikrobiomik, Seres Therapeutics, Vedanta Biosciences - Yahoo Finance

Yahoo Finance - Sep 07, 2026

Mary Jane Ferring - Fountain Hills Times Independent

Fountain Hills Times Independent - Apr 10, 2026

Arts Philanthropist John Ferring Dies at 73 - The Provincetown Independent

The Provincetown Independent - Apr 22, 2026

John H. Ferring IV, quiet builder of St. Louis arts and civic life, dies at 73 - STLPR

STLPR - Mar 04, 2026

RedHill acquires rights to Ferring’s Rebyota and Clenpiq - The Pharma Letter

The Pharma Letter - Sep 01, 2026

Ferring Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 30, 2026

Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building - Business Wire

Business Wire - Apr 16, 2026

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025 - biospace.com

biospace.com - Mar 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment